Month: March 2023

Rogers provides update to 2023 financial guidance to give effect to its acquisition of Shaw Communications

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

TORONTO, March 31, 2023 (GLOBE NEWSWIRE) — Rogers Communications Inc. today announced an update to its 2023 financial guidance ranges originally provided on February 2, 2023 to give effect to its anticipated acquisition of Shaw Communications Inc. (the “Shaw Transaction”). (In millions of dollars, except percentages; unaudited) 2022Actual Initial 2023Guidance Ranges 1 Updated 2023Guidance Ranges1 Consolidated Guidance Total service revenue 13,305 Increase of 4% to 7% Increase of 26% to 30%Adjusted EBITDA 2 6,393 Increase of 5% to 8% Increase of 31% to 35%Capital expenditures 3,4 3,075 3,100 to 3,300 $3,700 to $3,900Free cash flow 2,4 1,773 2,000 to 2,200 $2,000 to $2,2001 Guidance ranges presented as percentages reflect percentage increases over Rogers’ full-year 2022 results and includes the...

Rogers and Shaw to Proceed With Transformative Merger

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

Outside date of closing the transactions extended to April 7, 2023 TORONTO and CALGARY, Alberta, March 31, 2023 (GLOBE NEWSWIRE) — Rogers Communications Inc. and Shaw Communications Inc. announced today their historic merger is expected to close prior to the outside date of April 7, 2023 after receiving final regulatory approval. “We are very pleased to move forward with this transformative merger and proudly deliver on our commitments to enhance and expand network coverage, connect underserved communities, and improve access for low-income Canadians,” said Tony Staffieri, President and CEO, Rogers. “Building on a shared legacy with Shaw, we will invest substantially to bring more choice, more value, and more connectivity to Canadians across the country.” These merger commitments build on the two companies’ 50+ years of investing...

Rogers and Shaw to Proceed With Transformative Merger

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

Rogers, Shaw and Quebecor to Close Pro-Competitive Transactions

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

Companies Welcome Approval by Minister of Innovation, Science and Industry for the Transfer of Shaw’s Spectrum Licenses to Videotron Extend outside date of closing the transactions to April 7, 2023 TORONTO and CALGARY, Alberta and MONTREAL, March 31, 2023 (GLOBE NEWSWIRE) — After receiving federal government approval, Rogers Communications Inc., Shaw Communications Inc., and Quebecor Inc. announced today that they plan to close the pro-competitive transactions expeditiously. The three companies, along with the Shaw Family Living Trust, have agreed to extend the outside date of the acquisition of Freedom Mobile by Videotron Ltd., a wholly-owned subsidiary of Quebecor (the “Freedom Transaction”) and the closing of the merger of Rogers and Shaw (the “Rogers-Shaw Merger”) to April 7, 2023 and expect the transactions to close by that...

Rogers, Shaw and Quebecor to Close Pro-Competitive Transactions

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

Companies Welcome Approval by Minister of Innovation, Science and Industry for the Transfer of Shaw’s Spectrum Licenses to Videotron Extend outside date of closing the transactions to April 7, 2023 TORONTO and CALGARY and MONTREAL, March 31, 2023 (GLOBE NEWSWIRE) — After receiving federal government approval, Rogers Communications Inc., Shaw Communications Inc., and Quebecor Inc. announced today that they plan to close the pro-competitive transactions expeditiously. The three companies, along with the Shaw Family Living Trust, have agreed to extend the outside date of the acquisition of Freedom Mobile by Videotron Ltd., a wholly-owned subsidiary of Quebecor (the “Freedom Transaction”) and the closing of the merger of Rogers and Shaw (the “Rogers-Shaw Merger”) to April 7, 2023 and expect the transactions to close by that date. The...

Crown Electrokinetics Corp. Reports Year End 2022 Financial Results

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

LOS ANGELES, March 31, 2023 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in both designing and installing distributed antenna systems (DAS) and constructing fiber optic networks, today announced its year-end 2022 financial results. Corporate Updates During and Subsequent to the Fourth Quarter 2022Closed the asset acquisition of Amerigen 7, integrated organizations, and completed rebrand to Crown Fiber Optics Expanded to three customers including two new large telco infrastructure companies with estimated revenue potential up to $100 million Raised $7.1 million in Q1 2023 through a combination of debt and equity issuances Closed up to $100 million line of credit Advancing EK film productionDoug Croxall,...

Breaking the Mold: Biofuels Market Booms with Renewable Energy Push and Policy Backing

Written by Customer Service on March 31, 2023. Posted in Mergers And Acquisitions.

SkyQuest’s Biofuels market report is excellent information for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA, March 31, 2023 (GLOBE NEWSWIRE) — According to a recent analysis by SkyQuest, the Biofuels market is expected to achieve a market size of USD 234.85 billion by 2030, with a projected CAGR of 4.49% during the forecast period of 2022-2030. This growth can be attributed to the demand for renewable...

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed License Agreement with Baylor BioSciences to Commercialize INOpulse® in Greater China Strengthened Balance Sheet Through $5 Million Registered Direct Offering with Life Sciences-focused Institutional InvestorWARREN, N.J., March 31, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the year ended December 31, 2022. “We have achieved significant recent progress throughout our business, including advancing the INOpulse® clinical program, enhancing our regulatory and commercial prospects in China,...

Else Nutrition Reports an 82% increase in Fiscal Year 2022 Revenues

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

Conference call will be held on Friday, March 31 at 10 AM ET VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC (BABY) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler, and children nutrition company, today reported fourth quarter and fiscal year 2022 financial results for the period ending December 31, 2022. The financial statements and MD&A are available on SEDAR under the Company’s profile. Fourth Quarter and Fiscal Year 2022 Financial Highlights4Q22 revenues were $2.4M, an 86% increase versus $1.3M in 4Q21, and a 5% increase versus $2.2M in 3Q22. Revenue growth continued to be hampered by product shortages caused by a mechanical malfunction at the Company’s US facility. The demand for products remained very high, outstripping the available...

ContraFect Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Provides Business Update

Written by Customer Service on March 31, 2023. Posted in Earnings Releases And Operating Results.

YONKERS, N.Y., March 31, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announces business updates and financial results for the fourth quarter and full year ended December 31, 2022. “With the important support from our recent financings, we remain on track to both begin dosing patients in our Phase 1b/2 clinical study of intra-articular exebacase for the treatment of chronic prosthetic joint infections of the knee, and to file an IND for our second program, CF-370, for the treatment of Gram-negative infections, including resistant Pseudomonas, Acinetobacter and Klebsiella...

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals